Aspect Biosystems Closes $115M Series B Financing Round to Advance Bioprinted Tissue Therapeutics February 7, 2025
Aspect Biosystems Closes $115M Series B Financing Round to Advance Bioprinted Tissue Therapeutics February 7, 2025